Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
IntroductionDisease-modifying therapies (DMTs) have been shown to improve disease outcomes in multiple sclerosis (MS) patients. They may also impair the immune response to vaccines, including the SARS-CoV-2 vaccine. However, available data on both the …